LFMD Earnings & Financial Statements
LifeMD, Inc.
$2.41
+$0.04(+1.62%)
41
Overall
60
Value
18
Tech
47
Quality
Market Cap
$114.24M
Volume
154.91K
52W Range
$2.56 - $6.53
Target Price
$8.13
LFMD earnings and financial statements: LifeMD, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
LFMD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $194.06M | $154.82M | $152.55M | $119.03M | $92.88M |
| Cost of revenue | $27.71M | $21.44M | $18.90M | $18.67M | $18.00M |
| Operating income | -$7.67M | -$20.40M | -$14.49M | -$43.45M | -$54.30M |
| EBITDA | -$1.28M | -$13.81M | -$7.88M | -$39.61M | -$53.43M |
| Net income | $14.35M | -$21.41M | -$20.60M | -$45.54M | -$60.90M |
| EPS (diluted) | $0.25 | $-0.53 | $-0.70 | $-1.57 | $-2.29 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $70.41M | $76.10M | $58.48M | $25.67M | $49.92M |
| Total liabilities | $47.25M | $83.65M | $52.91M | $32.97M | $24.10M |
| Shareholders’ equity | $23.16M | -$9.08M | $3.51M | -$11.40M | $22.74M |
| Cash and equivalents | $36.80M | $32.65M | $33.15M | $3.96M | $41.33M |
| Long-term debt | $5.68M | $16.16M | $18.00M | $574.1K | $1.18M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $8.28M | $17.51M | $8.82M | -$22.94M | -$33.09M |
| Capital expenditure | -$9.52M | -$8.20M | -$8.73M | -$12.89M | -$3.40M |
| Free cash flow | -$1.24M | $9.31M | $86.9K | -$35.83M | -$36.49M |
| Dividends paid | $3.11M | $3.11M | $3.11M | $3.11M | $871.5K |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LFMD | $2.41 | +1.6% | 154.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |